Botox also helps relieve painNovember 10th, 2009 WASHINGTON - Botox not only fights wrinkles but is also a medication for chronic pain, a new study has said. Between five and 26 people out of every 100,000 have their lives significantly disrupted by some form of chronic pain.
Boston Scientific begins marketing next-generation stent in European UnionNovember 2nd, 2009 New Boston Scientific stent approved in EuropeNATICK, Mass. — Medical device maker Boston Scientific said Monday it received European marketing approval for its latest drug-coated stent technology, which prevents blocked arteries.
Seeing is relieving, when it comes to relief from chronic painOctober 30th, 2009 WASHINGTON - People who suffer from chronic pain can greatly improve their condition just by looking at the area where the pain is occurring, reveals an Anglo-Italian study. For the study, thirty healthy subjects were invited to look at either their own hand, the experimenter's hand, or an object, while their hand was subjected to laser-induced pain.
Phebra will handle approval and sales of Cumberland's Caldolor in Australia and New ZealandOctober 29th, 2009 Cumberland Pharma gets pain drug marketing partnerNEW YORK — Cumberland Pharmaceuticals Inc. said Thursday it found a marketing partner for its pain and fever drug Caldolor in Australia and New Zealand.
Sleep disorder, inflammation linked to heightened pain in arthritis patientsOctober 29th, 2009 WASHINGTON - A new study has found that inflammation and sleep problems are associated with increased pain in rheumatoid arthritis (RA) patients. Researchers from the Division of Rheumatology and Pain Management Center of Brigham and Women's Hospital, and the Chronic Pain and Fatigue Center of the University of Michigan Medical School, claim that while inflammation is linked to heightened pain sensitivity at joint sites, increased sleep problems are associated with heightened pain sensitivity at both joint and non-joint sites.
Botox shot can relieve chronic pain in peopleOctober 26th, 2009 WASHINGTON - Botox is more than just a solution to beat wrinkles. It can even be used as a pain medication to fight Chronic Regional Pain Syndrome (CRPS), according to a new study.
Higher vitamin D intake may help fight off back aches, pains in winterOctober 25th, 2009 WASHINGTON - Higher intake of vitamin D in winters can help people get rid of extra soreness and aches in their backs, say researchers. The study showed that patients with chronic back pain usually had inadequate levels of vitamin D and when sufficient vitamin D supplementation was provided, the pain either vanished or was at least helped to a significant extent.
Smoking can cause chronic lower back painOctober 24th, 2009 MELBOURNE - Canadian researchers have linked smoking to chronic lower back pain. In the study, boffins identified a higher rate of chronic lower back pain among people who smoke every day, reports News.com.au.
Now, recovery from chronic backache possibleOctober 8th, 2009 SYDNEY - Over a third of patients will recover from chronic low back pain within nine months and four out of 10 will do so within a year, according to a new research. This is the first study of its kind and the results go against the common view that recovery from an episode of chronic low backache is unlikely.
Depomed says its post-shingles pain drug succeeded it trial, and shares hit three-year highOctober 5th, 2009 Depomed says shingles pain drug meets study goalMENLO PARK, Calif. — Depomed Inc.
Drug combo better than individual medications for treating chronic painOctober 1st, 2009 WASHINGTON - A combination of two commonly prescribed drugs offers a much more effective treatment for people with debilitating neuropathic pain than if they take either of the medications individually, according to a study by Queen's University researchers. When given both an anti-seizure drug (gabapentin) and an antidepressant (nortriptyline), patients suffering from neuropathic pain caused by nerve damage or disease experienced less pain than when they took one or the other individually, reports Dr.
Adolor buys rights to Eli Lilly drug, plans studies on opioid bowel dysfunctionSeptember 21st, 2009 Adolor buys rights to Eli Lilly drugEXTON, Pa. — Biotechnology company Adolor Corp.
FDA approves Abbott Laboratories' test that screens for HIV types 1 and 2September 18th, 2009 FDA approves new HIV test from Abbott LaboratoriesWASHINGTON — The Food and Drug Administration has approved a new test from Abbott Laboratories that detects both types of the virus that causes AIDS. The FDA says the company's Abbott Prism HIV O Plus test can detect HIV types 1 and 2.
GlaxoSmithKline, Xenoport report positive midstage study results from potential pain drugSeptember 17th, 2009 Glaxo, Xenoport report positive pain drug studyNEW YORK — GlaxoSmithKline and Xenoport Inc. said Thursday their developing neuropathic pain treatment candidate met its key goal of lowering pain intensity in a midstage study.
Abbott Labs acquires Visiogen for $400M, expanding vision care product offeringsSeptember 2nd, 2009 Abbott acquires Visiogen for $400MABBOTT PARK, Ill. — Abbott Laboratories on Wednesday said it will acquire Visiogen Inc.
